Georges H. Mairesse
A5039109111- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Cardiac pacing and defibrillation studies
- Health Systems, Economic Evaluations, Quality of Life
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Syncope and Autonomic Disorders
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Heart Rate Variability and Autonomic Control
- Cardiovascular Function and Risk Factors
- Parkinson's Disease Mechanisms and Treatments
- Cardiovascular Effects of Exercise
- Pharmaceutical Economics and Policy
- Heart Failure Treatment and Management
- Transplantation: Methods and Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Sports injuries and prevention
- Neurology and Historical Studies
- Cardiac Valve Diseases and Treatments
- Viral Infections and Immunology Research
Cliniques du Sud Luxembourg
2016-2025
Liverpool Heart and Chest Hospital
2021-2022
University of Liverpool
2021-2022
Aalborg University
2021-2022
Azienda Ospedaliero-Universitaria di Modena
2022
University of Modena and Reggio Emilia
2022
Carol Davila University of Medicine and Pharmacy
2021
OLVG
2019
KLE Society Hospital
2018
Sir Ganga Ram Hospital
2018
Background— Among patients with implantable pacemakers and defibrillators, subclinical atrial fibrillation (SCAF) is associated an increased risk of stroke; however, there limited understanding their temporal relationship. Methods Results— The Asymptomatic Atrial Fibrillation Stroke Evaluation in Pacemaker Patients the Reduction Pacing Trial (ASSERT) enrolled 2580 pacemaker defibrillator aged ≥65 years a history hypertension but without fibrillation. Pacemakers cardioverter-defibrillators...
Given the advances in atrial fibrillation (AF) management and availability of new European Society Cardiology (ESC) guidelines, there is a need for systematic collection contemporary data regarding treatment AF ESC member countries. We conducted registry consecutive in- outpatients with presenting to cardiologists nine participating All patients an ECG-documented diagnosis confirmed year prior enrolment were eligible. enroled total 3119 from February 2012 March 2013, full on clinical subtype...
Subclinical atrial fibrillation is short-lasting and asymptomatic can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. associated an increased risk of stroke a factor 2.5; however, treatment oral anticoagulation uncertain benefit. We conducted trial involving patients subclinical lasting 6 minutes to 24 hours. Patients were randomly assigned in double-blind, double-dummy design receive apixaban at dose 5 mg twice daily (2.5 when indicated)...
The Atrial Fibrillation Ablation Pilot Study is a prospective registry designed to describe the clinical epidemiology of patients undergoing an atrial fibrillation (AFib) ablation, and diagnostic/therapeutic processes applied across Europe. aims 1-year follow-up were analyse how centres assess in routine practice success procedure evaluate rate long-term safety/complications.Seventy-two 10 European countries asked enrol 20 consecutive first AFib ablation procedure. A web-based case report...
The Atrial Fibrillation Ablation Pilot Study is a prospective, multinational registry conducted by the European Heart Rhythm Association of Society Cardiology that has been designed to describe clinical epidemiology patients undergoing an atrial fibrillation (AFib) ablation procedure, and diagnostic/therapeutic processes applied in these across Europe. We present results short-term (in-hospital) analysis. A total 72 centres 10 countries were asked enrol 20 consecutive scheduled for first...
Clinical complexity is increasingly prevalent among patients with atrial fibrillation (AF). The 'Atrial Better Care' (ABC) pathway approach has been proposed to streamline a more holistic and integrated AF care; however, there are limited data on its usefulness clinically complex patients. We aim determine the impact of ABC in contemporary cohort patients.From ESC-EHRA EORP-AF General Long-Term Registry, we analysed patients, defined as presence frailty, multimorbidity and/or polypharmacy. A...
The origin of 40% syncope cases remains unknown even after a complete diagnostic workup. Previous studies have suggested that ATP testing has value in selecting successful therapy. This patient-blinded, multicenter, randomized superiority trial tested whether, patients with origin, cardiac pacing those positive test leads to fewer recurrences than who do not receive pacing.From 2000 2005, 80 consenting (mean age, 75.9±7.7 years; 81% women; 56% without diagnosed structural heart disease) and...
Despite the increased prevalence of atrial fibrillation (AF), data for implementation nationwide screening programmes are limited. The aim this national study was to increase awareness about AF and stroke risk, determine in Belgian general population using an ECG handheld machine its feasibility identify new cases. We analysed obtained from 5 years 'Belgian Heart Rhythm Week' programme. All subjects were screened a one-lead machine. Among 65 747 screened, recorded 911, with overall 1.4% [95%...
Epidemiological studies in atrial fibrillation (AF) illustrate that clinical complexity increase the risk of major adverse outcomes. We aimed to describe European AF patients' phenotypes and analyse differential course.We performed a hierarchical cluster analysis based on Ward's Method Squared Euclidean Distance using 22 binary variables, identifying optimal number clusters. investigated differences management, use healthcare resources outcomes cohort patients from Europe-wide observational...
AimsCountry differences in management practices are evident, and the publication of guidelines by European Society Cardiology (ESC) other learned societies has tried to recommend a uniform evidence-based approach management. Despite availability efforts improve implementation, guideline adherence between countries regions within Europe therefore likely.
Background In the ICD Sports Safety Registry, death, arrhythmia- or shock-related physical injury did not occur in athletes who continue competitive sports after implantable cardioverter-defibrillator (ICD) implantation. However, data from non-competitive recipients is lacking. This report describes arrhythmic events and lead performance intensive recreational with ICDs enrolled European arm of compares their outcome those Registry. Methods The Registry recruited 317 ≥ 18 years old,...
Atrial fibrillation (AF) is a common arrhythmia in clinical practice. AF fulfils many of the criteria for screening programme. No data about prevalence non-hospitalized patients are available Belgium. The aim study was to assess feasibility and effectiveness nationwide-organized voluntary programme general population Belgium.A total 13.564 participants were screened, whom 10,758 older than 40 years (GSP group). Participants filled stroke risk stratification questionnaires (CHADS2...
Aims Overall, 40% of patients with atrial fibrillation are asymptomatic. The usefulness and cost-effectiveness screening programmes debated. We evaluated whether an programme a handheld electrocardiogram (ECG) machine in population-wide cohort has high yield is cost-effective. Methods used Markov-model based modelling analysis on 1000 hypothetical individuals who matched the Belgian Heart Rhythm Week programme. Subgroup analyses subjects ≥65 ≥75 years old were performed. Screening was...